Erhältlich:
Nicht auf Lager
Buch (Softcover): Fachbuch
Metabolic Syndrome Textbook For Clinicians
A Clinical Reference Covering Diagnostic Staging, Risk Stratification, and Guideline-Directed Therapeutics for Primary Care Physicians
Verlag:
Independently Published Unsere-Artikel-Nr.: P35295091
EAN: 9798188303761
Erhältlich:
Nicht auf Lager
Zustellung: Di, 13.10.2026
Versand: Kostenlos
-3.5 %
CHF 258.–
CHF 249.–
Beschreibung
When the Panel Looks Normal but the Risk Isn't. Built for the primary care physician reconciling a waist circumference, a borderline glucose, and a blood pressure that isn't quite hypertensive into one clinical picture, this reference traces metabolic syndrome from the insulin-resistant, inflamed adipocyte through every organ system it touches - cardiovascular, hepatic, renal, pulmonary, reproductive, and oncologic. It moves from molecular mechanism to the bedside decisions that mechanism drives, applying current staging, including the 2023 Cardiovascular-Kidney-Metabolic framework and the PREVENT risk equations, to thresholds this population's physiology quietly distorts. Every chapter runs on the Cardiometabolic Convergence System, a repeating decision-anchor at each major diagnostic branch point, consolidated in a closing, cross-referenced Atlas for point-of-care lookup. Inside, You Will Learn How To. - Reconcile ATP III, IDF, and harmonized diagnostic criteria. - and know which one to trust when a single patient meets two of the three. - Catch masked hypertension and hyperfiltration-stage kidney injury. - the two findings a reassuring office visit is most likely to miss. - Read a discordant lipid panel - apply apolipoprotein B and non-HDL-C to unmask atherogenic risk a normal LDL cholesterol hides. - Stage fibrosis before it becomes cirrhosis. - a structured FIB-4-to-elastography pathway that closes this population's best-documented screening gap. - Recognize HFpEF despite a normal natriuretic peptide - the obesity-specific blind spot that delays heart failure diagnosis. - Sequence GLP-1, dual-agonist, and SGLT2 therapy by risk profile, not glucose value alone. - matching agent to phenotype across diabetes, obesity, and kidney disease. - Select and monitor bariatric surgery patients for life -. procedure selection, diabetes remission timing, and the lifelong nutritional surveillance that follows. - Navigate PCOS, pregnancy, pediatric, and geriatric presentations. - the diagnostic adjustments standard adult thresholds don't make on their own. Keep this reference within reach for the next patient whose labs look fine and whose risk doesn't.
Spezifikationen
Sprache
- Englisch
Autor
- Benjamin M. Molina MD
Erscheinungsjahr
- 2026
Format
- Buch (Softcover)
Anzahl Seiten
- 358